|
Radiotherapy |
|
|
No radiotherapy
(n=87) |
Brachytherapy
(n=94) |
Externala
(n=89) |
Total
(n=270) |
P-value of chi-square test for heterogeneity |
N |
% |
N |
% |
N |
% |
N |
% |
|
Mean age (range) |
66.7 |
(38-91) |
64.9 |
(35-90) |
62.9 |
(33-81) |
64.8 |
(33-91) |
|
Age group |
|
|
|
|
|
|
|
|
|
70+ |
36 |
40 |
30 |
34 |
23 |
26 |
89 |
100 |
.092 |
50-69 |
43 |
26 |
60 |
37 |
61 |
37 |
164 |
100 |
|
<50 |
8 |
47 |
4 |
24 |
5 |
29 |
17 |
100 |
|
Period of diagnosis |
|
|
|
|
|
|
|
|
|
1980-1987 |
29 |
23 |
54 |
43 |
43 |
34 |
126 |
100 |
.005 |
1988-1996 |
58 |
40 |
40 |
28 |
46 |
32 |
144 |
100 |
|
Healthcare sector |
|
|
|
|
|
|
|
|
|
Private |
50 |
41 |
34 |
28 |
37 |
31 |
121 |
100 |
.012 |
Public |
37 |
25 |
60 |
40 |
52 |
35 |
149 |
100 |
|
Surgical treatment |
|
|
|
|
|
|
|
|
|
Hysterectomy with annexectomy |
80 |
32 |
87 |
34 |
86 |
34 |
253 |
100 |
.535 |
Hysterectomy without or unknown annexectomy |
7 |
41 |
7 |
41 |
3 |
18 |
17 |
100 |
|
Tumour risk category b |
|
|
|
|
|
|
|
|
|
Stage IB grade 1 |
52 |
44 |
55 |
47 |
10 |
9 |
117 |
100 |
.000 |
Stage IB grade 2 |
9 |
20 |
20 |
44 |
16 |
36 |
45 |
100 |
|
Stage IB grade 3 |
6 |
32 |
5 |
26 |
8 |
42 |
19 |
100 |
|
Stage IC grade 1 |
14 |
22 |
9 |
14 |
40 |
63 |
63 |
100 |
|
Stage IC grade 2 |
6 |
23 |
5 |
19 |
15 |
58 |
26 |
100 |
|
Risk category c |
|
|
|
|
|
|
|
|
|
Low risk |
61 |
38 |
75 |
46 |
26 |
16 |
162 |
100 |
.000 |
High risk |
26 |
24 |
19 |
18 |
63 |
58 |
108 |
100 |
|
aExternal = external radiotherapy with or without brachytherapy
bStage IB: myometrial invasion < 50% ; Stage IC: myometrial invasion >=50%
cLow risk: (Stage IB grade 1 and 2), High risk: (Stage IB grade 3 and Stage IC grade 1 and 2) |